GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

 

Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois

GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity, announced that new EndoBarrier data will be presented at Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois.

The schedule for the EndoBarrier presentations at DDW is as follows:

Efficacy and Safety of the EndoBarrier Gastrointestinal Liner on Obesity and Type 2 Diabetes: A Two Center Prospective Study
Date & Time: Saturday, May 6 from 12:00 – 2:00pm UTC
Session: ASGE Presentation │Bariatric
Presenter: Abdulla Alhassani, MD

Augmentation of Meal-Related Symptoms Following Placement of Duodenal-Jejunal Bypass Sleeve is a Potential Mechanism of Action Inducing Weight Loss
Date & Time: Sunday, May 7 from 12:00 – 2:00pm UTC
Session: AGA Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Jessica McMaster, Dietician

Improvements of Liver and Glycemic Parameters After Duodenal-Jejunal Bypass Sleeve (DJBS) Insertion
Date & Time: Sunday, May 7 from 12:00 – 2:00pm UTC
Session: ASGE Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Gerald Holtmann, MD

Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes
Date & Time: Monday, May 8 from 8:30 – 8:45am UTC
Session: ASGE Presentation │Surgical and Endoscopic Treatment of Obesity
Presenter: Pichamol Jirapinyo, MD

Is Re-Implantation of the Duodenal-Jejunal Bypass Liner Viable?
Date & Time: Monday, May 8 from 10:14 – 10:28am UTC
Session: AGA Presentation │New Bariatric Therapies for Obesity: Surgical and Nonsurgical
Presenter: Jurgen Stein, MD

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles